Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Friedland

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Expert Review of Clinical Pharmacology|February 6, 2014
Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infectionsEric Beresford, Donald Biek, Alena Jandourek, et al.
Diagnostic Microbiology and Infectious Disease|January 30, 2013
Assessment of ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia due to Streptococcus pneumoniae: insights from two randomized trialsAndrew F Shorr, Marin Kollef, Paul B Eckburg, et al.
Antimicrobial Agents and Chemotherapy|October 9, 2019
Safety, tolerability and pharmacokinetics of oral nafithromycin (WCK4873) after single or multiple doses and effects of food on single-dose bioavailability in healthy adult subjectsPiotr Iwanowski, Ashima Bhatia, Mugdha Gupta, et al.
International Journal of Antimicrobial Agents|June 11, 2017
Macrolide therapy for community-acquired pneumonia due to atypical pathogens: outcome assessment at an early time pointThomas M File, Paul B Eckburg, George H Talbot, et al.
Infectious Diseases in Clinical Practice (Baltimore, Md.)|January 10, 2015
Ceftaroline Fosamil for the Treatment of <i>Staphylococcus aureus</i> Bacteremia Secondary to Acute Bacterial Skin and Skin Structure Infections or Community-Acquired Bacterial PneumoniaJose A Vazquez, Christy R Maggiore, Phillip Cole, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 2010
CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infectionsG Ralph Corey, Mark H Wilcox, George H Talbot, et al.
Hospital Practice (1995)|February 26, 2014
Efficacy of ceftaroline fosamil for bacteremia associated with community-acquired bacterial pneumoniaAlena Jandourek, Alexander Smith, Lily Llorens, et al.
Antimicrobial Agents and Chemotherapy|July 12, 2017
Comparison of Plasma and Intrapulmonary Concentrations of Nafithromycin (WCK 4873) in Healthy Adult SubjectsKeith A Rodvold, Mark H Gotfried, Rakesh Chugh, et al.
Clinical Genitourinary Cancer|October 10, 2006
A phase II study of weekly paclitaxel/estramustine/carboplatin in hormone-refractory prostate cancerWilliam Berry, David Friedland, John Fleagle, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 2010
CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infectionsMark H Wilcox, G Ralph Corey, George H Talbot, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Expert Review of Clinical Pharmacology|February 6, 2014
Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infectionsEric Beresford, Donald Biek, Alena Jandourek, et al.
Diagnostic Microbiology and Infectious Disease|January 30, 2013
Assessment of ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia due to Streptococcus pneumoniae: insights from two randomized trialsAndrew F Shorr, Marin Kollef, Paul B Eckburg, et al.
Antimicrobial Agents and Chemotherapy|October 9, 2019
Safety, tolerability and pharmacokinetics of oral nafithromycin (WCK4873) after single or multiple doses and effects of food on single-dose bioavailability in healthy adult subjectsPiotr Iwanowski, Ashima Bhatia, Mugdha Gupta, et al.
International Journal of Antimicrobial Agents|June 11, 2017
Macrolide therapy for community-acquired pneumonia due to atypical pathogens: outcome assessment at an early time pointThomas M File, Paul B Eckburg, George H Talbot, et al.
Infectious Diseases in Clinical Practice (Baltimore, Md.)|January 10, 2015
Ceftaroline Fosamil for the Treatment of <i>Staphylococcus aureus</i> Bacteremia Secondary to Acute Bacterial Skin and Skin Structure Infections or Community-Acquired Bacterial PneumoniaJose A Vazquez, Christy R Maggiore, Phillip Cole, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 2010
CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infectionsG Ralph Corey, Mark H Wilcox, George H Talbot, et al.
Hospital Practice (1995)|February 26, 2014
Efficacy of ceftaroline fosamil for bacteremia associated with community-acquired bacterial pneumoniaAlena Jandourek, Alexander Smith, Lily Llorens, et al.
Antimicrobial Agents and Chemotherapy|July 12, 2017
Comparison of Plasma and Intrapulmonary Concentrations of Nafithromycin (WCK 4873) in Healthy Adult SubjectsKeith A Rodvold, Mark H Gotfried, Rakesh Chugh, et al.
Clinical Genitourinary Cancer|October 10, 2006
A phase II study of weekly paclitaxel/estramustine/carboplatin in hormone-refractory prostate cancerWilliam Berry, David Friedland, John Fleagle, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 2010
CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infectionsMark H Wilcox, G Ralph Corey, George H Talbot, et al.
Pageof 6